Pipeline
Eye-Related Products
Overview
YD Biopharma’s Eye-Related Product Line combines cutting-edge technology and innovative research to deliver advanced solutions for common and complex eye conditions. Through an exclusive partnership with 3D Biotech, YD Biopharma serves as the sole global distributor of their state-of-the-art eye care products. This collaboration ensures that our offerings, from contact lenses to therapeutic eye drops, are at the forefront of innovation, designed to enhance comfort, protect vision, and improve overall eye health.
Product
3D LensMate
EyeMate Contact Lenses
Product Classification & Regulatory Strategy
US FDA Registration &
Market Approval
European CE Mark
Japan PMDA
3D LensMate
Regulatory Status
In 2025, LensMate successfully obtained U.S. FDA Class 1 Medical Device designation.
FDA Registration Number: 3031092085.
Product Overview
LensMate is a next-generation ophthalmic solution designed to enhance eye comfort and health.
As a Class 1 Medical Device, it meets FDA safety and compliance standards, allowing for streamlined commercialization and market entry.
Next Steps
Expansion into global markets, leveraging its FDA Class 1 designation to pursue further regulatory approvals in Europe (CE Mark), Japan (PMDA), and other key markets.
Continued product development and innovation to enhance its ophthalmic applications and therapeutic potential.
3D LensMate combination with contact lens
Regulatory Status
In 2025, EyeMate successfully obtained U.S. FDA Class 1 Medical Device designation.
FDA Registration Number: 3031092085.
Product Overview
EyeMate is an innovative contact lens designed to improve eye health and comfort.
As a Class 1 Medical Device, it complies with FDA safety and regulatory standards, enabling a streamlined market entry process.
Next Steps
Expansion into international markets, leveraging its FDA Class 1 designation to seek regulatory approvals in Europe (CE Mark), Japan (PMDA), and other global regions.
Continued research and development to enhance the product’s therapeutic capabilities and ophthalmic applications.
